Mackenzie Financial »

Cara Therapeutics shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $40k 54k 0.74
2023-09-30 $51k 31k 1.62

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Bank Of Montreal Cadcom (BMO)
Canadian Natl Ry (CNI)
Canadian Pacific Kansas City (CP)
Apple (AAPL)
Canadian Natural Resources (CNQ)
Telus Ord (TU)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Stantec (STN)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Accenture Plc Ireland Shs Class A (ACN)

View all positions for Mackenzie Financial

Top funds holding Cara Therapeutics

Vanguard Group
Chescapmanager
Rosalind Advisors
Federated Investors
AQR Capital Management
Jacobs Levy Equity Management
Bank of America Corporation
Two Sigma Advisers
Millennium Management
Stifel Financial
Two Sigma Investments
Bnp Paribas Arbitrage, Snc
Charles Schwab Investment Management
GSA Capital Partners
Goldman Sachs Group

View all funds holding Cara Therapeutics